WeVote
Log In

Bill

Bill

HB 3357

Prohibits the sale of intravenous solution containers and intravenous tubing products intentionally made with DEHP

2026 Regular Session Introduced by Jeremy Dean

HB 3357 would ban the sale of DEHP-intentionally manufactured intravenous solution containers and IV tubing in Missouri.

Referred: Emerging Issues(H)
#businessandcommerce #consumerprotection #health #public
0
WeVote Research Nonpartisan
Bill Summary · HB 3357

Bill overview

HB 3357 (2026, Missouri) seeks to prohibit the sale of certain medical supply products—specifically intravenous solution containers and intravenous tubing products—that are intentionally manufactured with DEHP (di(2-ethylhexyl)phthalate). The measure is intended to reduce potential health risks associated with DEHP exposure in medical settings.

Main purpose and intent

  • Prohibits the sale of intravenous solution containers and intravenous tubing products that are intentionally made with DEHP.
  • Aims to limit patient and healthcare worker exposure to DEHP, a plasticizer found in some PVC medical devices.
  • Adds regulatory guardrails to ensure products used in IV therapy are DEHP-free.

Key provisions and changes

  • Scope of prohibition: The sale of intravenous solution containers and intravenous tubing products that are intentionally manufactured with DEHP is prohibited within Missouri.
  • Intent language: The bill targets products manufactured with DEHP on purpose, rather than incidental DEHP presence.
  • Enforcement and compliance: The text provided does not specify detailed enforcement mechanisms, penalties, or regulatory agency authority, but typical enactments include compliance requirements for retailers and manufacturers and potential penalties for violations. (Note: The exact enforcement provisions would be clarified in the full bill text.)
  • Effective date: The provided information does not include an explicit effective date; typically, bills specify an effective date after passage and signature.

Who or what would be affected

  • Manufacturers and suppliers of intravenous solution containers and intravenous tubing products that contain DEHP by design.
  • Retailers, distributors, and healthcare facilities that procure IV solution containers and IV tubing for patient care.
  • Potentially, entities that supply or stock DEHP-containing IV equipment would be required to transition to DEHP-free alternatives.

Procedural and timeline aspects

  • Introduction: HB 3357 was introduced and read first time on February 19, 2026.
  • Second reading: The bill was read a second time on February 23, 2026.
  • Referral: On May 15, 2026, the bill was referred to the Emerging Issues Committee (H).
  • Sponsorship: Co-sponsored by Jeremy Dean.

Potential impacts and considerations

  • Public health impact: Reducing DEHP exposure could be relevant for vulnerable populations (e.g., neonates, pediatric patients, patients requiring long-term IV therapy) where DEHP exposure has been a concern.
  • Economic and supply considerations: Hospitals and suppliers may need to identify and switch to DEHP-free alternatives, which could affect pricing, availability, and procurement processes.
  • Regulatory alignment: The bill may align Missouri policy with other states that have enacted DEHP-related restrictions or bans on certain IV medical devices.
  • Implementation challenges: Depending on the specificity of the prohibition and any phased timelines, facilities will need to audit inventories and ensure compliant products are used.

Summary

HB 3357 would ban the sale of intravenous solution containers and intravenous tubing products that are intentionally manufactured with DEHP in Missouri. The bill is currently moving through the legislative process, having been introduced in February 2026, referred to a committee in May, with co-sponsorship noted. If enacted, stakeholders in manufacturing, distribution, and clinical care would need to transition to DEHP-free IV equipment to comply with the prohibition.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.